제약·바이오업계동향
GC녹십자, 뉴라펙 임상 결과 국제학술지 게재·셀트리온, 아이덴젤트 유럽 진출
(서울=NSP통신) jeong seop park Jour = SK Bioscience, a leading South Korean bio company, is expeted to announce the record high 2021 earnings. The company plans to hold a press confernce next thursday. In the on-line confernce call, SK CEO plans to disclose the ongoing management issues including clinical trials for corona vaccines.
NSP News Agency jeong seop park Journalist desk@nspna.com
Copyright ⓒ Korea's economic news agency NSP NEWS·NSP TV. All rights reserved-Redistribution Prohibited.